UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...
Treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine are under review.
A new combination pill has been given the green light by the National Institute for Health and Care Excellence (Nice) to ...
But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific conference in San ...
Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...
1d
News-Medical.Net on MSNAlready approved drug avapritinib shows promise in treating high-grade gliomasHigh-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...
As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
The business conducted clinical trials of new potential drug treatments on behalf of sponsor companies seeking approval from ...
The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results